HOW TO USE VIDEO

Watch this video on how to use TUDORZA

Tudorza's Coverage Options May Lower
the Cost of Your Prescription
The Tudorza eVoucher Program

At participating pharmacies,* commercially insured patients may pay as little as $0 per prescription through the Tudorza eVoucher program†.

*Participating Pharmacy Lookup click here

Restrictions apply and co-pay amounts may vary. Subject to eligibility rules; restrictions apply. The eVoucher program is not valid for prescriptions that are eligible to be reimbursed, in whole or in part, by Medicaid, Medicare (including Medicare Part D and Medicare Advantage), TriCare, CHAMPUS, or any other local, state or federal healthcare programs, including state prescription drug assistance programs and the La Reforma de Salud program in Puerto Rico.

Covis Patient Assistance Program

Covis Patient Assistance Program is available for patients who cannot afford their Tudorza prescription.

COVIS Patient Assistance Program Application Form

INDICATION AND USAGE FOR TUDORZA® PRESSAIR® (aclidinium bromide inhalation powder)

TUDORZA PRESSAIR is a prescription medicine to treat chronic obstructive pulmonary disease (COPD). COPD is a long-term (chronic) lung disease that includes chronic bronchitis, emphysema, or both.

TUDORZA PRESSAIR is not a rescue medicine and should not be used for treating sudden breathing problems. Your doctor may give you other medicine to use for sudden breathing problems.

It is not known if TUDORZA PRESSAIR is safe and effective in children.

IMPORTANT SAFETY INFORMATION

Who should not use TUDORZA PRESSAIR?

Do not use TUDORZA PRESSAIR if you have a severe allergy to milk proteins, or are allergic to aclidinium bromide, or any of the ingredients in TUDORZA PRESSAIR. Ask your doctor if you are not sure.

What should I tell my doctor before using TUDORZA PRESSAIR?

Before you use TUDORZA PRESSAIR, tell your doctor about all your medical conditions, including if you have eye problems (especially glaucoma), prostate, or bladder problems, or problems passing urine. TUDORZA PRESSAIR may make these problems worse.

Tell your doctor if you are pregnant or plan to become pregnant. It is not known if TUDORZA PRESSAIR can harm your unborn baby. If you are breastfeeding or plan to breastfeed, TUDORZA PRESSAIR may pass into your breast milk. You and your doctor should decide if you will take TUDORZA PRESSAIR.

Tell your doctor about all the medicines you take, including prescription and over-the-counter medicines, eyedrops, vitamins and herbal supplements. TUDORZA PRESSAIR and certain other medicines may interact with each other causing serious side effects. Especially tell your doctor if you take other anticholinergics (including tiotropium, ipratropium, umeclidinium, glycopyrrolate) or atropine.

How should I use TUDORZA PRESSAIR?

Do not use TUDORZA PRESSAIR more often than prescribed or take more medicine than prescribed for you. Do not use other medicines that contain an anticholinergic for any reason. TUDORZA PRESSAIR does not relieve sudden symptoms of COPD and you should not use extra doses of TUDORZA PRESSAIR to relieve these sudden symptoms. Always have a rescue inhaler medicine with you.

Seek immediate medical help if your breathing problems worsen with TUDORZA PRESSAIR, you need to use your rescue inhaler more often than usual, or your rescue inhaler does not work as well for you at relieving symptoms.

What are the possible side effects of TUDORZA PRESSAIR?

TUDORZA PRESSAIR can cause serious side effects. Stop taking TUDORZA PRESSAIR and seek medical help right away if you experience:

  • Sudden breathing problems immediately after use of TUDORZA PRESSAIR
  • New or worsened increased pressure in your eyes (acute narrow-angle glaucoma), which may include eye pain or discomfort, nausea or vomiting, blurred vision, seeing halos or bright colors around lights, or red eyes. Using only eye drops to treat these symptoms may not work and if not treated, this could lead to permanent loss of vision
  • Symptoms of new or worsened urinary retention (difficult, painful, or frequent urination, or urination in a weak stream or drips)
  • Serious allergic reactions including rash; hives; swelling of the face, lips, tongue, or throat; breathing problems; and itching

What are the most common side effects of TUDORZA PRESSAIR?

The most common side effects of TUDORZA PRESSAIR include headache, common cold symptoms, and cough. In a long-term cardiovascular safety trial of up to 3 years, adverse reactions (occurring at a rate of ≥2% and more common than placebo) were nausea, back pain, cough, hypertension (high blood pressure), sinusitis (swelling of the sinuses), constipation, arthralgia (joint pain), anemia, muscle spasms, cardiac failure congestive (congestive heart failure), cellulitis (skin infection), and gastroesophageal reflux disease. These are not all the possible side effects of TUDORZA PRESSAIR.

To report SUSPECTED ADVERSE REACTIONS, contact Covis Pharma at 1-877-411-2510 or at medinfoUS@covispharma.com, or FDA at 1-800-FDA-1088 or www.fda.gov/medwatch.

Please also see the Full Prescribing Information, including Patient Information.

The information on this Website should not take the place of talking with your doctor or health care professional. If you have any questions about your condition, or if you would like more information about TUDORZA PRESSAIR, talk to your doctor or pharmacist. Only you and your health care professional can decide if TUDORZA PRESSAIR is right for you.

This product information is intended for US consumers only.

INDICATION AND USAGE FOR TUDORZA® PRESSAIR® (aclidinium bromide inhalation powder)

TUDORZA PRESSAIR is a prescription medicine to treat chronic obstructive pulmonary disease (COPD). COPD is a long-term (chronic) lung disease that includes chronic bronchitis, emphysema, or both.

TUDORZA PRESSAIR is not a rescue medicine and should not be used for treating sudden breathing problems. Your doctor may give you other medicine to use for sudden breathing problems.

It is not known if TUDORZA PRESSAIR is safe and effective in children.

IMPORTANT SAFETY INFORMATION

Who should not use TUDORZA PRESSAIR?

Do not use TUDORZA PRESSAIR if you have a severe allergy to milk proteins, or are allergic to aclidinium bromide, or any of the ingredients in TUDORZA PRESSAIR. Ask your doctor if you are not sure.

What should I tell my doctor before using TUDORZA PRESSAIR?

Before you use TUDORZA PRESSAIR, tell your doctor about all your medical conditions, including if you have eye problems (especially glaucoma), prostate, or bladder problems, or problems passing urine. TUDORZA PRESSAIR may make these problems worse.

Tell your doctor if you are pregnant or plan to become pregnant. It is not known if TUDORZA PRESSAIR can harm your unborn baby. If you are breastfeeding or plan to breastfeed, TUDORZA PRESSAIR may pass into your breast milk. You and your doctor should decide if you will take TUDORZA PRESSAIR.

Tell your doctor about all the medicines you take, including prescription and over-the-counter medicines, eyedrops, vitamins and herbal supplements. TUDORZA PRESSAIR and certain other medicines may interact with each other causing serious side effects. Especially tell your doctor if you take other anticholinergics (including tiotropium, ipratropium, umeclidinium, glycopyrrolate) or atropine.

How should I use TUDORZA PRESSAIR?

Do not use TUDORZA PRESSAIR more often than prescribed or take more medicine than prescribed for you. Do not use other medicines that contain an anticholinergic for any reason. TUDORZA PRESSAIR does not relieve sudden symptoms of COPD and you should not use extra doses of TUDORZA PRESSAIR to relieve these sudden symptoms. Always have a rescue inhaler medicine with you.

Seek immediate medical help if your breathing problems worsen with TUDORZA PRESSAIR, you need to use your rescue inhaler more often than usual, or your rescue inhaler does not work as well for you at relieving symptoms.

What are the possible side effects of TUDORZA PRESSAIR?

TUDORZA PRESSAIR can cause serious side effects. Stop taking TUDORZA PRESSAIR and seek medical help right away if you experience:

  • Sudden breathing problems immediately after use of TUDORZA PRESSAIR
  • New or worsened increased pressure in your eyes (acute narrow-angle glaucoma), which may include eye pain or discomfort, nausea or vomiting, blurred vision, seeing halos or bright colors around lights, or red eyes. Using only eye drops to treat these symptoms may not work and if not treated, this could lead to permanent loss of vision
  • Symptoms of new or worsened urinary retention (difficult, painful, or frequent urination, or urination in a weak stream or drips)
  • Serious allergic reactions including rash; hives; swelling of the face, lips, tongue, or throat; breathing problems; and itching

What are the most common side effects of TUDORZA PRESSAIR?

The most common side effects of TUDORZA PRESSAIR include headache, common cold symptoms, and cough. In a long-term cardiovascular safety trial of up to 3 years, adverse reactions (occurring at a rate of ≥2% and more common than placebo) were nausea, back pain, cough, hypertension (high blood pressure), sinusitis (swelling of the sinuses), constipation, arthralgia (joint pain), anemia, muscle spasms, cardiac failure congestive (congestive heart failure), cellulitis (skin infection), and gastroesophageal reflux disease. These are not all the possible side effects of TUDORZA PRESSAIR.

To report SUSPECTED ADVERSE REACTIONS, contact Covis Pharma at 1-877-411-2510 or at medinfoUS@covispharma.com, or FDA at 1-800-FDA-1088 or www.fda.gov/medwatch.

Please also see the Full Prescribing Information, including Patient Information.

The information on this Website should not take the place of talking with your doctor or health care professional. If you have any questions about your condition, or if you would like more information about TUDORZA PRESSAIR, talk to your doctor or pharmacist. Only you and your health care professional can decide if TUDORZA PRESSAIR is right for you.

This product information is intended for US consumers only.

Tudorza® is a registered trademark of Almirall, S.A. Pressair® is a registered trademark of the AstraZeneca group of companies.
PP-TUD-US-00087 8/23 © Covis Pharma GmbH All Rights Reserved.